The increasing incidence of visceral leishmaniasis relapse in South Sudan: A retrospective analysis of field patient data from 2001-2018.

The increasing incidence of visceral leishmaniasis relapse in South Sudan: A retrospective analysis of field patient data from 2001-2018.

<h4>Background</h4>Visceral Leishmaniasis (VL) is endemic in South Sudan, manifesting periodically in major outbreaks. Provision of treatment during endemic periods and as an emergency response is impeded by instability and conflict. Médecins Sans Frontières (MSF) has provided health car...

Full description

Bibliographic Details
Main Authors:	Gabriel Naylor-Leyland, Simon M Collin, Francis Gatluak, Margriet den Boer, Fabiana Alves, Abdul Wasay Mullahzada, Koert Ritmeijer
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2022-08-01
Series:	PLoS Neglected Tropical Diseases
Online Access:	https://doi.org/10.1371/journal.pntd.0010696

Similar Items

Correction: The increasing incidence of visceral leishmaniasis relapse in South Sudan: A retrospective analysis of field patient data from 2001-2018.
by: Gabriel Naylor-Leyland, et al.
Published: (2024-02-01)

A clinical severity scoring system for visceral leishmaniasis in immunocompetent patients in South Sudan.
by: Suzette S Kämink, et al.
Published: (2017-10-01)

Visceral leishmaniasis relapse in Southern Sudan (1999-2007): a retrospective study of risk factors and trends.
by: Stanislaw Gorski, et al.
Published: (2010-01-01)

Outcomes of visceral leishmaniasis in pregnancy: A retrospective cohort study from South Sudan.
by: Judith E Pekelharing, et al.
Published: (2020-01-01)

A Comparison of the Effectiveness of Sodium Stibogluconate Monotherapy to Sodium Stibogluconate and Paromomycin Combination for the Treatment of Severe Post Kala Azar Dermal Leishmaniasis in South Sudan - A Retrospective Cohort Study.
by: Charles Abongomera, et al.
Published: (2016-01-01)

Correction: The increasing incidence of visceral leishmaniasis relapse in South Sudan: A retrospective analysis of field patient data from 2001–2018
Published: (2024-02-01)

Determinants of Visceral Leishmaniasis: A Case-Control Study in Gedaref State, Sudan.
by: Fabienne Nackers, et al.
Published: (2015-11-01)

Control of visceral leishmaniasis in East Africa: fragile progress, new threats
by: Margriet den Boer, et al.
Published: (2021-08-01)

Visceral Leishmaniasis and HIV coinfection in East Africa.
by: Ermias Diro, et al.
Published: (2014-06-01)

The safety and efficacy of miltefosine in the long-term treatment of post-kala-azar dermal leishmaniasis in South Asia - A review and meta-analysis.
by: Joyce Pijpers, et al.
Published: (2019-02-01)

Burden of visceral leishmaniasis in villages of eastern Gedaref State, Sudan: an exhaustive cross-sectional survey.
by: Yolanda Kathrin Mueller, et al.
Published: (2012-01-01)

Anticipating visceral leishmaniasis epidemics due to the conflict in Northern Ethiopia.
by: Carl Boodman, et al.
Published: (2023-03-01)

Anticipating visceral leishmaniasis epidemics due to the conflict in Northern Ethiopia
by: Carl Boodman, et al.
Published: (2023-03-01)

Visceral leishmaniasis as an AIDS defining condition: towards consistency across WHO guidelines.
by: Johan van Griensven, et al.
Published: (2014-07-01)

Eco-epidemiology of visceral leishmaniasis in Ethiopia
by: Endalamaw Gadisa, et al.
Published: (2015-07-01)

Barriers to access to visceral leishmaniasis diagnosis and care among seasonal mobile workers in Western Tigray, Northern Ethiopia: A qualitative study.
by: Rebecca Marie Coulborn, et al.
Published: (2018-11-01)

Effectiveness and safety of short course liposomal amphotericin B (AmBisome) as first line treatment for visceral leishmaniasis in Bangladesh.
by: Emiliano Lucero, et al.
Published: (2015-04-01)

Visceral Leishmaniasis in pregnancy and vertical transmission: A systematic literature review on the therapeutic orphans.
by: Prabin Dahal, et al.
Published: (2021-08-01)

Epidemiological and molecular investigation of resurgent cutaneous leishmaniasis in Sudan
by: Sarah Collis, et al.
Published: (2019-11-01)

Use of Pentamidine As Secondary Prophylaxis to Prevent Visceral Leishmaniasis Relapse in HIV Infected Patients, the First Twelve Months of a Prospective Cohort Study.
by: Ermias Diro, et al.
Published: (2015-01-01)

Leishmania Antigenuria to Predict Initial Treatment Failure and Relapse in Visceral Leishmaniasis/HIV Coinfected Patients: An Exploratory Study Nested Within a Clinical Trial in Ethiopia
by: Johan van Griensven, et al.
Published: (2018-03-01)

Relationship of serum antileishmanial antibody with development of visceral leishmaniasis, post-kala-azar dermal leishmaniasis and visceral leishmaniasis relapse
by: Mondal, D, et al.
Published: (2019)

Relationship of Serum Antileishmanial Antibody With Development of Visceral Leishmaniasis, Post-kala-azar Dermal Leishmaniasis and Visceral Leishmaniasis Relapse
by: Dinesh Mondal, et al.
Published: (2019-10-01)

Risk factors of inpatients mortality of visceral leishmaniasis, Khartoum State, Sudan
by: Omaima Abdel Majeed Mohamed Salih, et al.
Published: (2020-01-01)

Hypokalaemia-induced rhabdomyolysis after treatment of post-Kala-azar dermal Leishmaniasis (PKDL) with high-dose AmBisome in Bangladesh-a case report.
by: Ulrika Marking, et al.
Published: (2014-06-01)

Sandflies (Diptera: Psychodidae) in a focus of visceral leishmaniasis in White Nile, Sudan
by: Sally Osman Widaa, et al.
Published: (2012-06-01)

Changes in the epidemiology of visceral leishmaniasis in Brazil from 2001 to 2014
by: Lisiane Lappe dos Reis, et al.

Outdoor Residual Insecticide Spraying (ODRS), a New Approach for the Control of the Exophilic Vectors of Human Visceral Leishmaniasis: Phlebotomus orientalis in East Africa.
by: Dia-Eldin A Elnaiem, et al.
Published: (2020-10-01)

Spatio-temporal modeling of visceral leishmaniasis in Midwest Brazil: An ecological study of 18-years data (2001-2018).
by: Everton Falcão de Oliveira, et al.
Published: (2020-01-01)

Spatio-temporal modeling of visceral leishmaniasis in Midwest Brazil: An ecological study of 18-years data (2001–2018)
by: Everton Falcão de Oliveira, et al.
Published: (2020-01-01)

Fractional-order modeling of visceral leishmaniasis disease transmission dynamics : strategies in eastern Sudan
by: Ghada A. Ahmed
Published: (2023-11-01)

Host, parasite and drug determinants of clinical outcomes following treatment of visceral leishmaniasis: a protocol for individual participant data meta-analysis
by: James Wilson, et al.
Published: (2023-10-01)

Haematological dynamics following treatment of visceral leishmaniasis: a protocol for systematic review and individual participant data (IPD) meta-analysis
by: James Wilson, et al.
Published: (2023-12-01)

Visceral leishmaniasis relapse in HIV patients--a role for myeloid-derived suppressor cells?
by: Rafael Van den Bergh, et al.
Published: (2014-09-01)

Predictors of relapse of visceral leishmaniasis in inner São Paulo State, Brazil
by: José Cláudio Simão, et al.
Published: (2020-06-01)

Towards the elimination of visceral leishmaniasis as a public health problem in east Africa: reflections on an enhanced control strategy and a call for action
by: Jorge Alvar, MD, et al.
Published: (2021-12-01)

Severe post-kala-azar dermal leishmaniasis successfully treated with miltefosine in an Ethiopian HIV patient
by: Charles Abongomera, et al.
Published: (2019-04-01)

Paromomycin for the treatment of visceral leishmaniasis in Sudan: a randomized, open-label, dose-finding study.
by: Ahmed M Musa, et al.
Published: (2010-10-01)

Mucosal relapse of visceral leishmaniasis in a child treated with anti-TNFα
by: E. Jeziorski, et al.
Published: (2015-04-01)

Effectiveness of miltefosine in cutaneous leishmaniasis caused by Leishmania tropica in Pakistan after antimonial treatment failure or contraindications to first line therapy-A retrospective analysis.
by: Suzette Kämink, et al.
Published: (2021-01-01)